Compare Marathon Petroleum Corp (MPC) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marathon Petroleum Corp vs Neurocrine Biosciences Inc — how do they compare? Marathon Petroleum Corp trades at $318.36 (market cap $92.05B), while Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B). The key difference: Marathon Petroleum Corp is far larger — about 5.3× Neurocrine Biosciences Inc's market cap, and Marathon Petroleum Corp pays a 1.24% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| MPC | NBIX | |
|---|---|---|
Market Cap | $92.05B | $17.40B |
Sector | Energy | Health |
52-Week High | $315.31 | $180.55 |
52-Week Low | $158.59 | $123.10 |
Enterprise Value | $124.23B | $16.49B |
Dividend Yield | 1.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
